Emerging Startup Pitches and Business Proposals
•Download as PPTX, PDF•
0 likes•822 views
Xavi Muñoz +34606849457 xavi@alphasip.es www.alphasip.es Parque Científico de Madrid C/ Faraday 7 28049 Madrid Thank you! Javier Martínez KNOWLEDGE MINERS
Recommended
More Related Content
Viewers also liked
Viewers also liked (13)
Similar to Emerging Startup Pitches and Business Proposals
Similar to Emerging Startup Pitches and Business Proposals (20)
Recently uploaded
Recently uploaded (20)
Emerging Startup Pitches and Business Proposals
- 1. Pitches from Emerging Startups Modera: Liz Fleming
- 3. Alejandro Alonso Puig QUARK ROBOTICS
- 4. CruiserBot Project Alejandro Alonso aalonso@quarkrobotics.com
- 5. Air ducts Respiratory problems Biological poluting agents
- 6. Sell Big and Heavy solutions, or Low quality solutions, or Good quality, but complex and expensive
- 7. INSPECTION • Portable • Modular • Easy to use • International + MODULES Ozone disinfection Cleaning
- 8. • Cleaning companies • Construction companies • Duct installation companies • Certification & Technical consultancy • Pest control companies • Civil Security • …and more as soon as we create additional modules
- 9. CEO: More than 15 years in • 8 shareholders management possitions in 4 (6 family + 2 friends) companies • 180K€ funding for R&D R&D people: more than 10 years and production of the 10 developing robotic solutions first saleable units Sales people: More than 20 years selling technical products
- 10. • Extend business to the rest of the country • Establish active business agreements in 4 more countries • 900.000€ revenue / 150 customers • 23% accumulated gross profit (36% in 2nd year) • Improve product, reduce manufacturing costs and produce additional modules • 200.000€ round of funding
- 11. More information and videos about the product: www.cruiserbot.com Alejandro Alonso Founder & CEO Quark Robotics aalonso@quarkrobotics.com Cell: +34-600912305
- 15. Business Need
- 16. Business Need
- 17. Business Need €3billion 100 000+ complaint s
- 18. Our Solution
- 20. Complexity of Complaints Competition cost/time per complaints
- 21. Business Model Resolution as a Service” Complaint <50 000 <200 000 200 000+ s/Year Cost €170,000 €680,000 €1,700,000
- 22. Projection Year 2012 2013 2014 Clients 3 8 16 Net €250,000 €890,000 €2.6M Revenue
- 23. Business Plan 2011 Expressed interest Cognicor Incorporated Product Development Beta Clients Ground Covered 2012 Acceleration by Wayra Paying Clients
- 24. Team Director Director CEO Product Development Business Development PhD in Artificial Intelligence Master of Computer Research Engineer MBA, ESADE Business Engineering Inventor of 6 US technology School Commercial Product patents Entrepreneur design & development Seasoned IT Consultant Telecom Industry Insurance Industry Expertise Expertise 7 years of USA work experience
- 25. In the Media Spinoff Winner Finalist BDigital Innovation Award, 2012
- 29. The founding team Mobility Scalability Backend Engineering Telecom Systems Engineering M&A Software Tech Engineerig Iñigo Serrano Eduard Giménez CEO CTO
- 35. 50 merchants with more than150 pilots
- 36. R O
- 38. • +33% Pilot Customers want it • 17k€ sold in 1 month and a half.
- 41. EU market over 1Bn € France United Kingdom Italy Argentina Portugal Belgium Netherlands Chile
- 43. • Seed 1 (12/11): 120k€ raised • Seed 2 (06/12): 100k€ secured • Series A (exp. 12/12): 800k€
- 49. doctordoctor “Health made easy” Matthieu Heusch CEO & Co-Founder
- 50. actual status
- 51. e-health market Private healthcare: 2,5% GDP +200.000 professionals +10.000.000 patients Andalucia saves €12M / year US: e-health = 0,5% GDP ($78B) + attractive industry for VCs
- 52. Doctor Doctor Communication & Relationship Patients & Doctors B2C B2B Online Booking Online Booking Health Alerts & Reminders Management App & CRM
- 53. how do we add value now? 1 SOFTWARE 1 INTEGRATION PROJECTS + 2 ONLINE BOOKING + + 3 ONLINE PRESENCE + 4 CRM +
- 54. how do we do it? B2B B2C 1 1 2 2 3 (white label) (white label)
- 55. achievements so far +700 +100.000 nominated for best european app RFP: white label worldwide reach : +15.000
- 56. our team Juan José Emilio Güemes Moraleda Healthcare Pharma Daniel Matt Chisco Enrique CTO CEO COO Alfredo Dans Technology Business Marketing Biel Technology & R&D & Partners & Product Health Tech
- 57. what are our next steps? 1 2
- 58. doctordoctor “Health made easy” @doctordoctores @matthieuheusch +34.665.93.17.64
- 61. • video
- 64. boring
- 66. COMPETITIVE MORE ENGAGING EDUCATIONAL
- 67. • VIDEO
- 69. Market Market Traders Fantasy Sports Online Gamers Players Social Gamers
- 70. 9,000,000 Swedes 1,000,000 readers Joined 100,000 real money stock tournament PAID €5 entry fee
- 71. 10 players €5 entry fee € 50 total 10% 90% €5 € 45 invoost winners
- 72. Competition Virtual Money Real Trading
- 73. Users
- 74. Affiliate Partner site with invoost invoost.com
- 75. invoost.com
- 76. 3.8 Million unique visits! 3.2 Million unique visits! Stock Championship invoost.com
- 77. Johan Wilsson (marketing) Tyler Maglione (operations) Jonathan Levy (product) German Abel del Zotto Muiño (developer) (developer)
- 78. What are we looking for? Investors Connectors Everyone 300k Partners Sign up! Go Live UK UK Marketing .com Germany Product development
- 79. • video Winners of: @invoost EmprendeGo www.invoost.com IE Venture Days hello@invoost.com
- 82. Leading Genetic Diagnostics Enrique Samper Ph.D. President esamper@nimgenetics.com
- 83. Juan Cruz Cigudosa, Ph.D, CSO Director Cytogenetics Lab Sara Alvarez , MD, Ph.D, CMO Chief Medical Geneticist Enrique Samper, Ph.D, CEO Molecular Biologist 12 employees, 7 Ph.D 83
- 84. mental retardation convulsions cardiac problems 10 yrs of medical tests unknown diagnostic 3 days, analyze the DNA Kleefstra syndrome
- 85. DNA arrays 100x more resolution fast (3d) 85
- 86. Specific arrays for early diagnostics Malformations/ Familial cancer Retardation/ Autism breast, colon and endocrine 2% world population 10% cancer patients innovative test designs definitive diagnostics 86 early treatment
- 87. 90% AGR in sales 50 Hospitals and Biotechs Cash flow + 2009 0,2M€ 2010 0,4M€ 2011 0,7M€ 2012e 1.3M€ National Market
- 88. competitors innovation in designs clinical experience excellent team international markets
- 89. international potential 2013 3M€ 2014 6M€ 89
- 90. we need your help 2M€ equity (Series A) leveraged 2M€ (Participative loans) internationalization new technology increase sales force
- 91. Thank you Parque Científico de Madrid C/ Faraday, 7 Campus de Cantoblanco 28049 Madrid Tel: +34 91 804 7760 Cell +34 647 426 518 esamper@nimgenetics.com
- 93. María Gómez del Pozuelo WOMENALIA
- 100. NanoChips for Medical diagnostics
- 101. UNEXPENSIVE CHIPS Bill Gates Foundation 700 million vaccines donation: Had saved at least 6,4 million lives bringing unexpensive care
- 102. Help Children to reach a better life & reforest the planet & Smart Energy EcoDesign
- 103. ACTUAL lifestyle OLD devices EXPENSIVE SLOW RESULTS
- 105. PREVENTION SERENDIPITY CARE
- 106. Fast reliable infarction fingertip Ipad Compatible
- 107. DETECTS 6 DRUGS ON A SALIVA SIP INSTANT DETECTION
- 108. Digital Signal Read out results The ASI nanoprocessor, processes the digital signal inside the chip
- 109. PhD Brent M. Segal, PhD Miguel Roncalés MD Javier Roncalés, PhD Xavi Muñoz
- 110. Spin off Harvard Brent Segal wrotes 122 Patents Nantero (2001) - aszenszor (2006) 400 Patents on Nanotubes Memories AlphaSIP (2008) is created for Blood Uses LM adquires Space, Defense & Energy AlphaSIP CAJAL4EU 24 Mill EUR ENIAC LM Send Nantero Memory to Space
- 113. We target the most expensive assays Cardio, Lethal Infectious Diseases & CTCs… … Saving costs Moore´s law (Flat TV Paradigm)
- 114. NANOTECH saves lives • Nanotechnology is an applied science field dedicated to the control and manipulation of the matter in a scale smaller than a micrometer (atomic and molecular scale) •A nanometer is the thousand millionth part of a meter (10-9 meters)
- 115. EVOLUTION Femtomolar Sensitivity 2016 with adequate funding MOLAR CONCENTRATION Basic R&D limited Robust Preclinical & Clinical few cases Proof of Concept Essays “Atto” Zepto Atto Femto Pico Nano Micro Milli M (mol/L) 10-21 10-18 10-15 10-12 10-9 10-6 10-3 1 10 100 1 10 100 1 10 100 1 10 100 1 10 100 1 10 100 1 10 100 1 Nat, PCR, Enzymatic Immunoassays Direct & enzymatic Examples:
- 116. MARKET OVER - 1,8 BILLION EUR Main Figures • In Vitro Diagnostics market world-wide: 48.000 Mill EUR (2010) • European Coagulation market: 600 Mill EUR (2010) • 85.000 yearly infarctions in Spain, 28.000 deaths/year
- 117. DUAL BUSINESS MODEL • Business model maybe similar to other semicon providers like Intel strategy of convey “Intel Inside” on larger products defined by Global Leading IVD Suppliers to take advantage of the depth of their distribution capabilities OEM 80% “Alphasip Inside” 20%
- 118. STRONG IP POSITION CARDIOSIP • 8 own Patents +400 Patents licensed CVD The IEEE (Institute of Electric Engineers, 375.000 patrons in 160 countries) ranked in its January 2010 report the Nantero IP in 2nd place worldwide in the semicon industry and top 10 in overall industries 400 PATENTS NANTERO CNTS FIELD EFFECT TRANSISTOR
- 119. OUR INDUSTRIAL PARTNERS & CAJAL4EU
- 120. Multiply by 10x the investment in 4 years 78% IRR Chip process facilitate mass production & significant growth
- 121. ALPHASIP ADVANTAGE RESULTS ON IPAD & ANDROID BRIDGING POC & CENTRAL LABS CURRENT METHODS ALPHASIP’s alternative to ELISA method - Fast diagnostic (1 to 3 min) - High sensitivity & specificity - From 1 hour to 2 weeks - Requires expert personnel - Low unit cost - Ease of use - High unit cost -“Nano”. Need less antibodies - Simple integration with - Device size - Portable device communication systems - Intrusive methods - Low sensitivity Revolution (tablets, cell phones) DIGITAL SIGNAL
- 122. Contact Information: Miguel Roncalés (PhD) +34626004107 +34976512887 mroncales@alphasip.es
Editor's Notes
- This is not a just video, you are looking at our product on the screen.We have worked and self funded the project and have a working prototype.We are very excited because we will be ready to launch in June.
- Market Trading -Online Gaming -€25B Worldwide 2010 -Double by 2013Social Gaming 1 in 5 facebook usersFantasy Sports $4B industry
- We should be able to be better than that. We have a better product, and dozens of tournaments per day not one per year. But it’s not just us that think we can do better, the e24 ceo who loves the product and has given us detailed product advice expects the same.However, for our financials we are playing it safe and assume we only get 10% ...
- We should be able to be better than that. We have a better product, and dozens of tournaments per day not one per year. But it’s not just us that think we can do better, the e24 ceo who loves the product and has given us detailed product advice expects the same.However, for our financials we are playing it safe and assume we only get 10% ...
- (boring / safe)(exciting / risky)
- So we have our product ready, how are we going to get users in the system
- You may be familiar how games, such as farmville are embedded within facebook
- E24 pan europeanscandinaviaWe are building relationships with many of them, are trying to sign 2 to 3 of them before we go live … but we only need one to be profitable..playing it safe
- Two slides? Don’t say conservative… we should change the numbers put 10,000 users.
- Nimgenetics has been growing at 100% in revenues per year.This year we will get about 1.4 million from the spanish market, on 2013 we are starting operations in mercosur and plan to get to 3M in revenues, and on 2014 we´ll expand to central europe and get 6M
- Such great market has of course some competitors such as Bioarray and qgenomics in Spain and OGT and Bluegnome in the UKBUT the team in Nimgenetics can blow the competion away because: we continiously innovate, we use our great medical and scientific knowledge to create great array designs and we are going international
- To do this we NEED 2M and leverage it with another 2M with participated loans and CDTI programs. We´ll INVEST this money for internationalization in Europe, to complete the teamTo buy upcoming tech and to increase our sales force.